Velaglucerase Alfa
CAS 884604-91-5Biologic
Overview
Velaglucerase alfa is an enzyme replacement therapy used for the treatment of Gaucher's disease, a condition where fatty substances accumulate in certain organs. It acts by replacing the deficient glucocerebrosidase enzyme, helping to break down accumulated lipids in patients.
Therapeutic areas
Gaucher Disease
Verified Supplier Partner
Do you supply Velaglucerase Alfa? Get in front of buyers actively sourcing it.
We route real sourcing requests from pharma buyers to vetted, verified partners — qualified leads, not just a listing. Tell us what you make and we'll be in touch about becoming a Verified Supplier Partner.
Ready to Accelerate Your
Discovery Workflow?
Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 7 days.